Country selection
To offer the best possible experience tailored to your national regulatory requirements and the available product portfolio, please choose your country from the following list. This option will be saved throughout the browser session. Thank you!
User experience & privacy
We use cookies to offer you an optimal website experience. This includes cookies necessary for the operation of the website and for the control of our commercial corporate goals, as well as those only used for anonymous statistical purposes, comfort settings or to display personalized content. Please note that based on your settings, not all functions of the website may be available. To find out more, please refer to our Data Privacy Statement.

Eckert & Ziegler signs agreement to sell its cyclotron division to Alliance Medical

Berlin, Germany

Eckert & Ziegler Radiopharma GmbH, a subsidiary of Eckert & Ziegler AG (ISIN DE 0005659700), signed an agreement today on the sale of its entire cyclotron division to Alliance Medical Ltd. Eckert & Ziegler will receive a payment in cash in the amount of € 13,0 million in return. The corporate division being sold generated sales of around € 18 million in 2016, accounting for approximately 13 % of consolidated sales and only a small profit contribution. The sale will be effective as of today.

For further information or questions, please contact:
Eckert & Ziegler AG, Karolin Riehle, Investor Relations
Robert-Rössle-Str. 10, 13125 Berlin, Germany
Phone: +49 (0) 30 / 94 10 84-138,,

Additional text:
“As part of the realignment of the Radiopharma segment, the Executive Board has decided to focus on globally scalable products and services”, explained Dr. André Heß, Member of the Executive Board of Eckert & Ziegler AG and Head of the Radiopharma segment. “Our cyclotron based products, which are sold in Germany and some neighboring regions only, do not fit into this category. Due to their short half life cyclotron based products can only be sold within driving distance from the production facilities. Growth potential is therefore limited. Building new cyclotrons in other parts of the world only offers low returns on investment, since competitors already have strong positions in nearly all foreign markets. Well established players such as Alliance Medical, by contrast, who run cyclotron chains in different countries, can realize synergy effects to their core business through this acquisition”.
Howard Marsh, Head of Alliance Medicals Radiopharmacy division said: “The acquisition of Eckert & Zieglers cylclotron division further extends our Molecular Imaging presence in Northern Europe, supplementing both our PET/CT scanning services across the region as well as our radiopharmacy facilities in the UK and Italy. By creating the largest European integrated Radiotracer supply and Imaging organization, we are able to offer a range of solutions to meet all customers needs.”

About Eckert & Ziegler
With around 670 employees, Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700) is one of the world’s largest providers of isotope components for radiation therapy and nuclear medicine.
Contributing to saving lives.

About Alliance Medical
Alliance Medical is Europe’s leading diagnostic and molecular imaging services provider delivering high quality diagnostic solutions in partnership with public and private organisations.

Note: The press release has been copied from


Get in touch

Contact us regarding your questions and we will get back to you as soon as possible.
By clicking send, you give your consent for processing your personal data in accordance with our Data Privacy Statement.
Permission required
In order to submit your request it is required to load a 3rd-party service (Google Re-Captcha spam protection system). You current privacy settings prevent this from happening automatically. By clicking the button below you explicitly allow to temporarily (on this page) load 3rd party services.